FDA-approved device to detect macular degeneration raising $2 million
A company with a medical device to detect early onset of age-related macular degeneration, the leading cause of blindness in adults ages 50 or older, is raising $2 million in a series A preferred financing round to commercialize its diagnostic tool, which was approved by the U.S. Food and Drug Administration last year. Apeliotus Vision […]